DK0429242T3 - Specifikke bindingsmidler - Google Patents

Specifikke bindingsmidler

Info

Publication number
DK0429242T3
DK0429242T3 DK90312407.1T DK90312407T DK0429242T3 DK 0429242 T3 DK0429242 T3 DK 0429242T3 DK 90312407 T DK90312407 T DK 90312407T DK 0429242 T3 DK0429242 T3 DK 0429242T3
Authority
DK
Denmark
Prior art keywords
human antibody
reshaped
specific binding
binding agents
plap
Prior art date
Application number
DK90312407.1T
Other languages
English (en)
Inventor
Martine Elisa Verhoeyen
Original Assignee
Unilever Plc
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898926045A external-priority patent/GB8926045D0/en
Priority claimed from GB909019552A external-priority patent/GB9019552D0/en
Application filed by Unilever Plc, Unilever Nv filed Critical Unilever Plc
Application granted granted Critical
Publication of DK0429242T3 publication Critical patent/DK0429242T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dental Preparations (AREA)
  • Paper (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Fireproofing Substances (AREA)
DK90312407.1T 1989-11-17 1990-11-14 Specifikke bindingsmidler DK0429242T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898926045A GB8926045D0 (en) 1989-11-17 1989-11-17 Specific binding agents
GB909019552A GB9019552D0 (en) 1990-09-07 1990-09-07 Specific binding agents

Publications (1)

Publication Number Publication Date
DK0429242T3 true DK0429242T3 (da) 1995-10-16

Family

ID=26296218

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312407.1T DK0429242T3 (da) 1989-11-17 1990-11-14 Specifikke bindingsmidler

Country Status (16)

Country Link
EP (1) EP0429242B1 (da)
JP (1) JPH05501357A (da)
KR (2) KR970007782B1 (da)
AT (1) ATE123815T1 (da)
AU (1) AU652923B2 (da)
BG (1) BG60687B1 (da)
CA (1) CA2066670A1 (da)
DE (1) DE69020112T2 (da)
DK (1) DK0429242T3 (da)
ES (1) ES2075169T3 (da)
FI (1) FI922220L (da)
GR (1) GR3017407T3 (da)
HU (1) HUT64600A (da)
NO (2) NO303066B1 (da)
RO (1) RO110262B1 (da)
WO (1) WO1991007500A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019553D0 (en) * 1990-09-07 1990-10-24 Unilever Plc Specific binding agents
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
JP5297742B2 (ja) * 2008-09-26 2013-09-25 株式会社青木科学研究所 金型用粉体含有油性潤滑剤、これを用いた静電塗布方法、及び静電塗布装置
EP3383920B1 (en) * 2015-11-30 2024-01-10 The Regents of the University of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
EP3806894A4 (en) 2018-06-12 2022-06-08 Promab Biotechnologies, Inc. PLAP-CAR EFFECTOR CELLS
US20240101677A1 (en) 2021-01-27 2024-03-28 Innovent Biologics (Suzhou) Co., Ltd. Single-domain antibody against cd16a and use thereof
MX2024003887A (es) 2021-10-14 2024-07-09 Arsenal Biosciences Inc Células inmunitarias que tienen arnch coespresados y sistemas de compuerta lógica.
CN114014933B (zh) * 2021-11-17 2023-05-02 福州迈新生物技术开发有限公司 抗plap蛋白单克隆抗体、细胞系及其制备方法和应用
EP4766737A1 (en) * 2023-08-25 2026-07-01 Axcynsis Therapeutics Pte. Ltd. Anti-PALP/PALPL2 antibodies, antibody-drug combinations and their uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product

Also Published As

Publication number Publication date
DE69020112T2 (de) 1995-11-02
AU652923B2 (en) 1994-09-15
NO921941L (no) 1992-05-15
RO110262B1 (ro) 1995-11-30
EP0429242A3 (en) 1991-06-05
DE69020112D1 (de) 1995-07-20
ATE123815T1 (de) 1995-06-15
AU6736990A (en) 1991-06-13
KR920703837A (ko) 1992-12-18
EP0429242A2 (en) 1991-05-29
EP0429242B1 (en) 1995-06-14
JPH05501357A (ja) 1993-03-18
KR970007783B1 (ko) 1997-05-16
FI922220A0 (fi) 1992-05-15
WO1991007500A1 (en) 1991-05-30
FI922220A7 (fi) 1992-05-15
BG96346A (bg) 1993-12-24
KR970007782B1 (ko) 1997-05-16
NO921941D0 (no) 1992-05-15
GR3017407T3 (en) 1995-12-31
NO980656L (no) 1992-05-15
HUT64600A (en) 1994-01-28
ES2075169T3 (es) 1995-10-01
FI922220L (fi) 1992-05-15
HU9201619D0 (en) 1992-08-28
NO980656D0 (no) 1998-02-16
BG60687B1 (bg) 1995-12-29
NO303066B1 (no) 1998-05-25
CA2066670A1 (en) 1991-05-18

Similar Documents

Publication Publication Date Title
ATE233279T1 (de) Spezifisch bindende agentien
NO921941L (no) Spesifikke bindingsmidler
PT99934A (pt) Processo para a producao de um anticorpo anti-htnf alfa recombinante ou humanizado
DK25084A (da) Human-human hybridoma mod neoplasmer
DE69633717D1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
BR9708910A (pt) Anticorpo conjugado sequência de polinucleotídeos vetor célula hospedeira hibridoma composição farmacêutica processos para fabricar um anticorpo ou um conjugado e para tratar um humano ou animal em necessidade deste tratamento
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
DK392387D0 (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
BG99074A (bg) Рекомбинантни човешки нiv-неутрализиращи моноклонални антитела за профилактика и лечение на нiv инфекция
NO174110C (no) Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet
DE69334036D1 (de) Hybridom und humanisierter monoklonaler anti-kc-4-antikörper, dafür kodierende dnas und rnas, kit und diagnostische verfahren
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
FR2697088B1 (fr) Anticorps monoclonaux pour le diagnostic différentiel de cancers épithéliaux dans des épanchements séreux, hybridomes les secrétant et kit de diagnostic.
DE3852914D1 (de) Monoklonale Antikörper und Diagnoseverfahren für Phytophthora-Infektionen.
EP0453419A3 (en) Use of the sp-2 monoclonal antibody for diagnostics and for monitoring of the hiv infection progress
DE3787220D1 (de) Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma.
DK1414859T5 (da) Monoklonale anti-SSRP-1-antistoffer og hybridomer som producerer antistofferne
DE3375516D1 (en) Monoclonal antibody specific for human blood group antigen k (cellano), and hybridoma cell lines producing these monoclonal antibodies
ATE84069T1 (de) Murin-hybridoma lym-2 und diagnostikantikoerper, der dadurch hergestellt ist.
DK182188A (da) Humant tumorassocieret antigen